Skip to Content

Tag: pediatric patients

Also Noted

Inspire OK’d for use in kids 

March 21, 2023HME News Staff

MINNEAPOLIS – Inspire Medical Systems has received approval from the U.S. Food and Drug Administration to offer its obstructive sleep apnea therapy to pediatric patients with Down syndrome. The approval includes patients with Down syndrome who are at least 13 years old, with an apnea hypopnea index between 10 and 50, and who do not have the ability to benefit from CPAP. “Since our first FDA approval in 2014, the research team at Mass Eye and Ear, led by Dr. Christopher Hartnick,...

Inspire Medical Systems, Obstructive Sleep Apnea (OSA), pediatric patients

Read Full Articlered right arrow icon